24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol

By LaForce Craig   Korenblat Phillip   Osborne Pamela   Dong Fang   Higgins Mark  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2353-2359

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma

By Brookman Laurence J.   Knowles Lisa J.   Barbier Michaela   Elharrar Brigitte   Fuhr Rainard   Pascoe Steve  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3113-3122

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil^®/Aerolizer^™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 13-19

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (Aerolizer^TM) and Placebo (pMDI or Aerolizer^TM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite

Comparison of an Inhaled Corticosteroid (Triamcinolone Acetonide) to a Long–Acting Bronchodilator (Salmeterol), the Combination, and Placebo in Mild–Moderate Adult Asthmatic Patients

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 345-346

Karger

Access to resources Recommend Favorite